Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

U.S. Wireless Cardiac Monitoring Systems Market Size, Share, and Forecast 2026-2033 Featuring Profiles of Philips, iRhythm Technologies, Abbott, Medtronic, Biotronik (Teleflex) and More

globenewswire.com

U.S. Wireless Cardiac Monitoring Systems Market Size, Share, and Forecast 2026-2033 Featuring Profiles of Philips, iRhythm Technologies, Abbott, Medtronic, Biotronik (Teleflex) and More Dublin, Oct. 20, 2026 (GLOBE NEWSWIRE) -- "U.S. Wireless Cardiac Monitoring Systems Market Size, Share & Trends Analysis Report by Test Type, Product Type, Indication, End Use, Payer Type, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.

The U.S. wireless cardiac monitoring systems market was valued at an estimated USD 2.4 billion in 2025 and is projected to reach USD 5.2 billion by 2033. The market is expected to expand at a compound annual growth rate of 10.1% from 2026 to 2033, supported by reimbursement expansion, increasing rates of cardiac rhythm disorders, and wider adoption of advanced remote monitoring technologies.

Growing reimbursement coverage for extended ECG services and remote cardiac monitoring is improving patient access to diagnostic testing across the United States. Payer-backed remote patient management programs are also encouraging healthcare providers to integrate connected monitoring solutions into routine cardiac care. These developments are expected to strengthen demand across hospitals, clinics, ambulatory centers, telehealth platforms, and home care settings.

AI-enabled wearable devices and patch-based monitoring systems are becoming increasingly important within the U.S. wireless cardiac monitoring systems market. These technologies support longer monitoring periods, efficient data analysis, and improved diagnostic accuracy. Cloud connectivity, real-time transmission, automated interpretation, and physician validation are also helping healthcare organizations manage cardiac data more effectively.

The continued shift toward outpatient and home-based monitoring is another major market driver. Telehealth integration enables providers to monitor patients beyond conventional clinical environments, while extended-wear devices support the detection of intermittent cardiac events. This transition is creating opportunities for medical device manufacturers, digital health companies, diagnostic service providers, and remote monitoring platforms.

Market Segmentation Covered in the Report

The report analyzes country-level revenue growth and key U.S. wireless cardiac monitoring systems market trends across sub-segments from 2021 to 2033. The analysis is organized by test type, product type, indication, end use, and payer type.

Test Type Outlook

Product Type Outlook

Indication Outlook

End Use and Payer Outlook

The report evaluates adoption across Hospitals & Clinics, Ambulatory / Diagnostic Centers, Telehealth Providers, Home Care Settings, Cardiac Rehabilitation Programs, and other care environments. Payer analysis covers Medicare, Medicaid, and Private Insurance, providing insight into how reimbursement structures influence technology adoption and patient access.

Strategic Value of the Report

The report provides a focused assessment of the factors shaping the U.S. wireless cardiac monitoring systems market, including reimbursement policy, telehealth adoption, clinical demand, connected device innovation, and the expansion of home-based cardiac care.

Key Attributes

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/a3v751

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.